Digest Network Come funziona
Network
/
Società
Mi
Non verificato

Mirum Pharmaceuticals, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieMercato azionarioSalute

51 comunicati stampa

Guarda tutti i comunicati
01/12/2025
Industria
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Mirum Pharmaceuticals Announces First Patient Enrolled in the BLOOM Phase 2 Clinical Study Evaluating MRM-3379 in Fragile X Syndrome
Fonte
Mirum Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
25/11/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Eventi
Web e Social Network
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
Fonte
Mirum Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
11/11/2025
Mercato del lavoro
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Mirum Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
07/11/2025
Eventi
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD’s The Liver Meeting®
Fonte
Mirum Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
04/11/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Telefonia e Varie
Mercato azionario
Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Fonte
Mirum Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
03/11/2025
Finanza
Igiene alimentare
Biotecnologia
Medicina - Varie
Associazioni/Professionisti
Salute
Farmaceutica
Eventi
Web e Social Network
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
Fonte
Mirum Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
28/10/2025
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Igiene alimentare
Medicina - Varie
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
Fonte
Mirum Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
10/10/2025
Biotecnologia
Farmaceutica
Salute
Mercato azionario
Finanza
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Mirum Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
10/09/2025
Biotecnologia
Farmaceutica
Salute
Mercato azionario
Finanza
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Mirum Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
08/09/2025
Biotecnologia
Farmaceutica
Salute
Industria
Mirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS Study
Fonte
Mirum Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0